儒博实业 ROP 深 沪
等待开盘 11-18 09:30:00 美东时间
443.88
-5.620
-1.25%
华盛通- 最 高449.97
- 今 开448.66
- 成交量 65.22万股
- 最 低 443.50
- 昨 收 449.50
- 总市值 479.39亿
- 52周最高 592.6918
- 市盈率 静 30.94
- 换手率 0.60%
- 52周最低 435.42
- 委 比 -50.40%
- 总股本 1.08亿
- 历史最高 592.6918
- 量 比 0.77
- 振 幅 1.44%
- 历史最低 41.405
- 每 手 1
- 风险率 34.49%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Roper Technologies strengthens AI leadership with key executive appointments
Roper Technologies has appointed Shane Luke as Senior Vice President of AI and Edward Raffaele as Vice President of AI Engineering to enhance AI capabilities across its software businesses. Luke and Raffaele bring extensive experience in AI strategy and implementation, aiming to accelerate AI-driven growth and innovation. Roper, a market leader in vertical software, emphasizes AI's role in strengthening customer value and long-term growth. Both e...
11-10 13:30
Roper Technologies Hikes Quarterly Cash Dividend From $0.82 To $0.91 Per Share
Roper Technologies, Inc. (NASDAQ:ROP) announced that its Board of Directors has declared a quarterly cash dividend of $0.91 per share, reflecting a 10% increase compared to the prior quarterly dividend, payable on
11-06 03:04
META joins the group of most oversold Nasdaq-100 stocks
Wall Street’s Nasdaq Composite (COMP:IND) and Nasdaq-100 Index (NDX) have come under pressure recently, as traders and investors have moved to de-risk portfolios over the past week, despite Wednesday’...
11-06 02:08
Roper Technologies announces dividend to 10% - its 33rd consecutive annual dividend increase
<p>Roper Technologies, Inc. (Nasdaq: ROP) announced a 10% increase in its quarterly cash dividend to $0.91 per share, marking the 33rd consecutive year of dividend growth. The dividend is payable on January 16, 2026, to stockholders of record on January 2, 2026. The increase reflects Roper's commitment to enhancing shareholder value through disciplined capital redeployment and high-quality acquisitions.</p>
11-05 19:00
Nuvini Posts Capital Markets Update Webcast with Management Transcript
Nuvini Group Limited announced its Capital Markets Update, highlighting a transition to USD reporting for enhanced transparency, senior management's increased ownership, disciplined capital allocation with a minimum 30% cash-on-cash return, AI-driven operational efficiency via Oracle partnership, and a scalable platform targeting 35–45% EBITDA margins, strong organic growth, and over $100 million in EBITDA within five years. CEO Pierre Schurmann ...
11-05 13:05
Nuvini Continues To Expect FY25 EBITDA $9M-$11M
Over the next three to five years, Nuvini targets:35 to 45% consolidated EBITDA margins, consistent with best-in-class vertical SaaS peers;Strong annual organic revenue growth driven by recurring subscriptions, high
11-03 21:11
Nuvini Outlines Long-Term Operating Targets Highlighting Scalable SaaS Model
Nuvini Group Limited (NASDAQ: NVNI) announced its long-term operating and profitability targets. Management recently purchased shares using personal funds, reflecting confidence in the company's strategy. Nuvini will now report financial metrics in USD to enhance transparency and comparability. Over the next three to five years, the company aims for 35-45% consolidated EBITDA margins, strong organic growth driven by recurring subscriptions and cr...
11-03 13:00
财报速睇 | 儒博实业2025财年Q3营收20.18亿美元，股权持有人应占溢利3.99亿美元
华盛资讯11月1日讯，ROPER TECHNOLOGIES INC公司今日公布2025财年Q3业绩，公司Q3营收20.18亿美元，同比增长14.3%，股权持有人应占溢利3.99亿美元，同比增长8.3%。
11-02 11:57
A Look at Atlassian's Upcoming Earnings Report
Atlassian (NASDAQ:TEAM) will release its quarterly earnings report on Thursday,...
10-30 00:03
美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
10-28 10:08
